shortage tirzepatide Eli Lilly's is off the FDA's drug list: Here's what it means tirzepatide off the shortage list

The critical difference: Mounjaro (tirzepatide) is FDA approved and available by prescription today, while Retatrutide remains in Phase 3 clinical trials with projected approval in late 2026 to early 2027

If you're exploring stronger outcomes, PlexusDx also offers tirzepatide, a dual GLP-1/GIP receptor agonist that targets two appetite pathways simultaneously and has shown weight loss of up to 22% in clinical trials

Obesity is a major risk factor for numerous health conditions, including type 2 diabetes, heart disease, and certain cancers

Create a wind-down routine

Title: Retatrutide Peptide Retatrutide peptide is a new kind of triple receptor agonist